J Virol. 1990 January; 64(1): 215-221
Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells.
B Chesebro,
R Buller,
J Portis and
K Wehrly
National Institute of Allergy and Infectious Diseases, Rocky Mountain Laboratories, Hamilton, Montana 59840.
ABSTRACT
CD4 molecules on human cells function as a major receptor for human immunodeficiency virus (HIV); however, certain CD4-negative cell types may also be susceptible to infection. Therefore, we attempted to quantitate the relationship between HIV infection and CD4 expression on human cell lines before and after introduction of the CD4 gene by using a retrovirus vector. Prior to introduction of the CD4 expression vector, low levels of HIV infection were detected by a sensitive focal immunoassay on all three cell types studied. With several HIV strains in clones of human cervical carcinoma (HeLa) cells expressing different levels of CD4, HIV titer increased with increasing CD4 expression. In contrast, in squamous cell carcinoma cells (SCL1) and astroglial cells (U87MG), even high levels of CD4 expression failed to augment HIV infection. The CD4 protein expressed in these two cell lines had the expected molecular weight and was capable of binding HIV virions. However, in contrast to CD4-positive HeLa cells, CD4-positive U87MG and SCL1 cells were unable to form syncytia when cultured with cells expressing HIV envelope protein. Thus, the inability of HIV to infect these cells appeared to be due to lack of fusion between HIV virion envelope proteins and CD4-positive cell membranes. This block is infectivity was overcome when cells were infected with HIV which was pseudotyped with the envelope protein of amphotropic murine leukemia virus. Thus, in addition to CD4, other cell surface molecules appear to be required for successful HIV entry into and infection of these two human cell lines.
J Virol. 1990 January; 64(1): 215-221
This article has been cited by other articles:
-
Vermeire, K., Schols, D.
(2005). Cyclotriazadisulfonamides: promising new CD4-targeted anti-HIV drugs. J Antimicrob Chemother
56: 270-272
[Abstract]
[Full Text]
-
Daecke, J., Fackler, O. T., Dittmar, M. T., Krausslich, H.-G.
(2005). Involvement of Clathrin-Mediated Endocytosis in Human Immunodeficiency Virus Type 1 Entry. J. Virol.
79: 1581-1594
[Abstract]
[Full Text]
-
Billick, E., Seibert, C., Pugach, P., Ketas, T., Trkola, A., Endres, M. J., Murgolo, N. J., Coates, E., Reyes, G. R., Baroudy, B. M., Sakmar, T. P., Moore, J. P., Kuhmann, S. E.
(2004). The Differential Sensitivity of Human and Rhesus Macaque CCR5 to Small-Molecule Inhibitors of Human Immunodeficiency Virus Type 1 Entry Is Explained by a Single Amino Acid Difference and Suggests a Mechanism of Action for These Inhibitors. J. Virol.
78: 4134-4144
[Abstract]
[Full Text]
-
Vermeire, K., Schols, D.
(2003). Specific CD4 down-modulating compounds with potent anti-HIV activity. J. Leukoc. Biol.
74: 667-675
[Abstract]
[Full Text]
-
Doms, R. W., Trono, D.
(2000). The plasma membrane as a combat zone in the HIV battlefield. Genes Dev.
14: 2677-2688
[Full Text]
-
Shimizu, N., Soda, Y., Kanbe, K., Liu, H.-y., Mukai, R., Kitamura, T., Hoshino, H.
(2000). A Putative G Protein-Coupled Receptor, RDC1, Is a Novel Coreceptor for Human and Simian Immunodeficiency Viruses. J. Virol.
74: 619-626
[Abstract]
[Full Text]
-
Kozak, S. L., Kuhmann, S. E., Platt, E. J., Kabat, D.
(1999). Roles of CD4 and Coreceptors in Binding, Endocytosis, and Proteolysis of gp120 Envelope Glycoproteins Derived from Human Immunodeficiency Virus Type 1. J. Biol. Chem.
274: 23499-23507
[Abstract]
[Full Text]
-
Genoud, S., Kajumo, F., Guo, Y., Thompson, D., Dragic, T.
(1999). CCR5-Mediated Human Immunodeficiency Virus Entry Depends on an Amino-Terminal gp120-Binding Site and on the Conformational Integrity of All Four Extracellular Domains. J. Virol.
73: 1645-1648
[Abstract]
[Full Text]
-
Pleskoff, O., Treboute, C., Alizon, M.
(1998). The Cytomegalovirus-Encoded Chemokine Receptor US28 Can Enhance Cell-Cell Fusion Mediated by Different Viral Proteins. J. Virol.
72: 6389-6397
[Abstract]
[Full Text]
-
Rabut, G. E. E., Konner, J. A., Kajumo, F., Moore, J. P., Dragic, T.
(1998). Alanine Substitutions of Polar and Nonpolar Residues in the Amino-Terminal Domain of CCR5 Differently Impair Entry of Macrophage- and Dualtropic Isolates of Human Immunodeficiency Virus Type 1. J. Virol.
72: 3464-3468
[Abstract]
[Full Text]
-
Lacasse, R. A., Follis, K. E., Moudgil, T., Trahey, M., Binley, J. M., Planelles, V., Zolla-Pazner, S., Nunberg, J. H.
(1998). Coreceptor Utilization by Human Immunodeficiency Virus Type 1 Is Not a Primary Determinant of Neutralization Sensitivity. J. Virol.
72: 2491-2495
[Abstract]
[Full Text]
-
Lee, B., Doranz, B. J., Ratajczak, M. Z., Doms, R. W.
(1998). An Intricate Web: Chemokine Receptors, HIV-1 and Hematopoiesis. Stem Cells
16: 79-88
[Abstract]
[Full Text]
-
Dragic, T., Trkola, A., Lin, S. W., Nagashima, K. A., Kajumo, F., Zhao, L., Olson, W. C., Wu, L., Mackay, C. R., Allaway, G. P., Sakmar, T. P., Moore, J. P., Maddon, P. J.
(1998). Amino-Terminal Substitutions in the CCR5 Coreceptor Impair gp120 Binding and Human Immunodeficiency Virus Type 1 Entry. J. Virol.
72: 279-285
[Abstract]
[Full Text]
-
Hori, T., Sakaida, H., Sato, A., Nakajima, T., Shida, H., Yoshie, O., Uchiyama, T.
(1998). Detection and Delineation of CXCR-4 (Fusin) as an Entry and Fusion Cofactor for T Cell-Tropic HIV-1 by Three Different Monoclonal Antibodies. J. Immunol.
160: 180-188
[Abstract]
[Full Text]
-
Samson, M., LaRosa, G., Libert, F., Paindavoine, P., Detheux, M., Vassart, G., Parmentier, M.
(1997). The Second Extracellular Loop of CCR5 Is the Major Determinant of Ligand Specificity. J. Biol. Chem.
272: 24934-24941
[Abstract]
[Full Text]
-
Lu, Z.-h., Berson, J. F., Chen, Y.-h., Turner, J. D., Zhang, T.-y., Sharron, M., Jenks, M. H., Wang, Z.-x., Kim, J., Rucker, J., Hoxie, J. A., Peiper, S. C., Doms, R. W.
(1997). Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proc. Natl. Acad. Sci. USA
94: 6426-6431
[Abstract]
[Full Text]
-
Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S., Landau, N. R.
(1997). Change in Coreceptor Use Correlates with Disease Progression in HIV-1-Infected Individuals. J. Exp. Med.
185: 621-628
[Abstract]
[Full Text]
-
Patience, C, McKnight, A, Clapham, P., Boyd, M., Weiss, R., Schulz, T.
(1994). CD26 antigen and HIV fusion?. Science
264: 1159-1160
Copyright © 1990 by the American Society for Microbiology. All rights reserved.